TV

Tanvi Vivek Londhe

Director Director DIN 07075045
DIN 07075045 First appointment Jan 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2015
Shareholding value •••• Premium profile

About Tanvi Vivek Londhe

Data last updated:

Tanvi Vivek Londhe was a Director at Cresco Enterprise Private Limited (2015–2019) and Director at Adisan Biotechnologies Private Limited (2015–2017). The companies operate in Trading and Pharma.

DIN 07075045
Primary Designation Director
Industry Trading
First Appointment 20 Jan 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cresco Enterprise Private Limited U01403PN2014PTC153419
Director20 Jan 20152014Strike Off
Director10 Jun 20152012₹32,286 (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cresco Enterprise Private Limited
Adisan Biotechnologies Private Limited
Premium access

Shareholding and investment profile for Tanvi Vivek Londhe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tanvi Vivek Londhe

Tanvi Vivek Londhe was first appointed on 20 Jan 2015 as Director at Cresco Enterprise Private Limited.

Tanvi Vivek Londhe held 2 earlier board appointments: Cresco Enterprise Private Limited (Director, 20 Jan 2015 to 13 Jun 2019); Adisan Biotechnologies Private Limited (Director, 10 Jun 2015 to 04 Mar 2017).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available